3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoid Interstitial Pneumonia
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Cholangiocarcinoma
1
Interventions
Cytarabine
5
Whole-Body Irradiation
4
fludarabine
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Cyclophosphamide
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
nilotinib
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
asciminib
2
Tacrolimus
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
dehydroftorafur
×
30 days
×
Clear all
No trials found.